Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Clinical characteristics and outcomes of gastrointestinal stromal tumor patients receiving surgery with or without TKI therapy: a retrospective real-world study

Fig. 4

Prognostic analysis of 124 patients diagnosed with “very” high-risk: overall survival (A) and disease-free survival (B) between “very” high-risk patients and normal–high-risk patients; the overall survival (C) and disease-free survival (D) among different TKI maintenance treatment time. TKI: Tyrosine kinase inhibitor

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us